News and Trends 30 Jun 2022
Funding doubled for company working on breakthrough auto-immune disease therapeutics
A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it has almost doubled its initial funding from two companies. The initial funding for Ermium Therapeutics…